Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in children

Canadian Journal of Clinical Pharmacology

Volumn 12, Issue 3, 2005, Pages

  Lau, Loretta ^a   Baruchel, Sylvain ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Canada; Neoplasms; Paediatrics; Phase I clinical trials; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

CANADA; CANCER CENTER; CANCER RECURRENCE; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; QUESTIONNAIRE; REVIEW;

EID: 30744445444     PISSN: 1198581X     EISSN: 17106222     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Smith MA, Gloeckler Ries LA. Childhood cancer: incidence, survival, and mortality. In: Pizzo PA, Poplack DG, ed. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2002:1-12.
2. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19(13):3163-72.
3. Pratt CB. The conduct of phase I-II clinical trials in children with cancer. Med Pediatr Oncol 1991;19(4):304-9.
4. Smith M, Bernstein M, Bleyer WA, et al. Conduct of phase I trials in children with cancer. J Clin Oncol 1998;16(3):966-78.
5. Health Canada. Cancer surveillance on-line. Cancer incidence by age group. http://dsol-smed.hc-sc.gc.ca/dsol-smed/cgi-bin/cancerchart2?DATA_TYPE= D&AGE_GROUPS=T%3BU%3BV%3BW&CAUSE2=019&YEAR2=00&AREA2= 00&SEX2=3&CAGE2=View+Chart&SCALE=LINEAR (May 18, 2004).
6. Health Canada. Cancer surveillance on-line. Cancer mortality by age group. http://dsol-smed.hc-sc.gc.ca/dsol-smed/cgi-bin/cancerchart2?DATA_TYPE= D&AGE_GROUPS=T%3BU%3BV%3BW&CAUSE2=019&YEAR2=00&AREA2= 00&SEX2=3&DATA_SET=MORT&CAGE2=View+Chart&SCALE=LINEAR (May 18, 2004).
7. National Childhood Cancer Foundation. Childhood cancer treatment and research centers. http://www.nccf.org/help/references.asp?cat=13&catName= CHILDHOOD%20CANCER%20TREATMENT%20AND%20RESEARCH%20CENTERS#results (May 18, 2004).
8. Estlin EJ, Cotterill S, Pratt CB, Pearson AD, Bernstein M. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group. J Clin Oncol 2000; 18(9): 1900-5.
9. Shah S, Weitman S, Langevin AM, Bernstein M, Furman W, Pratt C. Phase I therapy trials in children with cancer. J Pediatr Hematol Oncol 1998;20(5):431-8.
10. Langevin AM, Weitman SD, Kuhn JG, et al. Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol 2003;25(7):526-33.
11. Wells RJ, Reid JM, Ames MM, et al. Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 2002;24(2):89-93.
12. Health Canada. Cancer surveillance on-line. Cancer incidence by site. http://dsol-http://dsol-smed.hc-sc.gc.ca/dsol-smed/cgi-bin/cancerchart2? DATA_TYPE=D_HBAR1&CAUSE=ALL&YEAR=00&AREA=00&AGE=T&SEX= 2&CCAUSE1=View+Chart (May 18, 2004).